JYNT Fundamental Analysis - JOINT CORP/THE

Fundamental Rating

Taking everything into account, JYNT scores 3 out of 10 in our fundamental rating. JYNT was compared to 101 industry peers in the Health Care Providers & Services industry. JYNT has a great financial health rating, but its profitability evaluates not so good. JYNT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

JYNT had negative earnings in the past year.

JYNT had a positive operating cash flow in the past year.

In multiple years JYNT reported negative net income over the last 5 years.

JYNT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

JYNT has a Return On Assets of -6.82%. This is in the lower half of the industry: JYNT underperforms 70.30% of its industry peers.

JYNT's Return On Equity of -21.48% is on the low side compared to the rest of the industry. JYNT is outperformed by 65.35% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROIC	N/A

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

JYNT has a Gross Margin of 81.48%. This is amongst the best in the industry. JYNT outperforms 95.05% of its industry peers.

In the last couple of years the Gross Margin of JYNT has declined.

The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	81.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, JYNT has more shares outstanding

Compared to 5 years ago, JYNT has more shares outstanding

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

JYNT has an Altman-Z score of 3.15. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.

JYNT has a Altman-Z score of 3.15. This is in the better half of the industry: JYNT outperforms 63.37% of its industry peers.

JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	3.15

ROIC/WACCN/A

WACC8.68%

2.3 Liquidity

JYNT has a Current Ratio of 1.80. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.80, JYNT is in the better half of the industry, outperforming 65.35% of the companies in the same industry.

A Quick Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.80, JYNT is in the better half of the industry, outperforming 66.34% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.8
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.41%, which is quite impressive.

JYNT shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.

Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

3.2 Future

Based on estimates for the next years, JYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 73.24% on average per year.

Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -20.57% on average per year.

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue Next Year-54.02%

Revenue Next 2Y-28.81%

Revenue Next 3Y-20.57%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

A Price/Forward Earnings ratio of 27.75 indicates a quite expensive valuation of JYNT.

The rest of the industry has a similar Price/Forward Earnings ratio as JYNT.

The average S&P500 Price/Forward Earnings ratio is at 22.88. JYNT is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.75

4.2 Price Multiples

JYNT's Price/Free Cash Flow ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	46.55
EV/EBITDA	N/A

4.3 Compensation for Growth

JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

JYNT's earnings are expected to grow with 73.24% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y91.85%

EPS Next 3Y73.24%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for JYNT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JOINT CORP/THE

NASDAQ:JYNT (9/18/2025, 8:00:02 PM)

After market: 10.26 0 (0%)

10.26

+0.24 (+2.4%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)08-07 2025-08-07/amc

Earnings (Next)11-05 2025-11-05/amc

Inst Owners74.55%

Inst Owner Change5.03%

Ins Owners7.04%

Ins Owner Change3.9%

Market Cap157.39M

Analysts78.18

Price Target15.17 (47.86%)

Short Float %3.99%

Short Ratio8.61

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.93%

Min Revenue beat(2)-2.34%

Max Revenue beat(2)-1.53%

Revenue beat(4)1

Avg Revenue beat(4)-12.67%

Min Revenue beat(4)-51.14%

Max Revenue beat(4)4.33%

Revenue beat(8)3

Avg Revenue beat(8)-6.08%

Revenue beat(12)4

Avg Revenue beat(12)-4.64%

Revenue beat(16)6

Avg Revenue beat(16)-3.78%

PT rev (1m)-3.25%

PT rev (3m)-3.25%

EPS NQ rev (1m)-100%

EPS NQ rev (3m)-100%

EPS NY rev (1m)-115%

EPS NY rev (3m)-104.35%

Revenue NQ rev (1m)-1.03%

Revenue NQ rev (3m)-3.38%

Revenue NY rev (1m)-1.62%

Revenue NY rev (3m)-1.84%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	27.75
P/S	1.45
P/FCF	46.55
P/OCF	33.18
P/B	6.77
P/tB	6.77
EV/EBITDA	N/A

EPS(TTM)-0.24

EYN/A

EPS(NY)0.37

Fwd EY3.6%

FCF(TTM)0.22

FCFY2.15%

OCF(TTM)0.31

OCFY3.01%

SpS7.07

BVpS1.51

TBVpS1.51

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.82%
ROE	-21.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	81.48%
FCFM	3.12%

ROA(3y)-7.05%

ROA(5y)1.52%

ROE(3y)-28.39%

ROE(5y)0.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

F-Score6

Asset Turnover1.48

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	52.4%
Cap/Sales	1.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.8
Quick Ratio	1.8
Altman-Z	3.15

F-Score6

WACC8.68%

ROIC/WACCN/A

Cap/Depr(3y)57.36%

Cap/Depr(5y)93.23%

Cap/Sales(3y)6.25%

Cap/Sales(5y)6.57%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)72.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%53.85%

EPS Next Y97.68%

EPS Next 2Y91.85%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue 1Y (TTM)-9.68%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56.15%

Revenue Next Year-54.02%

Revenue Next 2Y-28.81%

Revenue Next 3Y-20.57%

Revenue Next 5YN/A

EBIT growth 1Y-162.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year302.99%

EBIT Next 3Y74.18%

EBIT Next 5YN/A

FCF growth 1Y-70.37%

FCF growth 3Y6.31%

FCF growth 5Y15.29%

OCF growth 1Y-71.9%

OCF growth 3Y-12.05%

OCF growth 5Y4.6%

JOINT CORP/THE (JYNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens